Brief: Toleranzia Conducts Safety Study Of TOL2
31/05/2024 06:52
May 31 (Reuters) - Toleranzia AB TOLE.ST :
* CONDUCTS SUCCESSFUL SAFETY STUDY OF TOL2 IN BLOOD SAMPLES
FROM
PATIENTS WITH MYASTHENIA GRAVIS
Source text for Eikon: ID:nMFN4y6k4T
Further company coverage: TOLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Toleranzia AB
See all newsBrief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A
Brief: Toleranzia Q2 Net Income SEK -2.911 Million
Brief: Nasdaq Stockholm Approves Toleranzia’S Application For Delisting
Brief: Toleranzia Applies For Delisting Of Shares On Nasdaq
Brief: Toleranzia Approves Merger Plan Adopted By Boards Of Toleranzia, Flerie